AUR-103

N/A

Report date: 2026/04/18 20:00:19

Base Information

Drug NameAUR-103
Drug Alias NameAUR-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action +[1N/A
TargetsCluster of differentiation 47
Therapy Area/IndicationsGastroesophageal Junction NeoplasmsSolid tumoursMyelodysplastic Syndromes +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAurigene
China Registration ClassN/A

Develop Information

Active CompaniesAurigene
Active IndicationsLeukemia
Inactive IndicationsGastroesophageal Junction NeoplasmsSolid tumoursMyelodysplastic Syndromes +[6

Other Information

ATC CodeN/A
Related LinksN/A